Abstract
The interaction of T-helper cells and autoreactive B-lymphocytes in the initiation of autoimmune processes is discussed resulting in the hypothesis that this interaction not only leads to the production of autoantibodies but also to the induction of cellular autoimmune processes. Based on this hypothesis, the immunopharmacological properties of a new immunomodulating drug, Ciamexone, are discussed.